New York Times -- As Japan races to avoid a nuclear disaster, some Americans and companies in the United States are scrambling to obtain potassium iodide, a drug that can protect people from radiation-induced thyroid cancer. “We’ve sold more in the past three days than we have in the past three years,” said Jim Small, president of the American arm of Recipharm, a Swedish company that is a major supplier of potassium iodide.
